These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27555120)

  • 41. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
    Korkmaz C
    Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
    [No Abstract]   [Full Text] [Related]  

  • 43. [Kidney damage in primary antiphospholipid syndrome].
    Kozlovskaia NL; Tareeva IE; Kamyshova ES; Varshavskiĭ VA; Miroshnichenko NG; Kotliarova GV
    Ter Arkh; 2001; 73(6):25-31. PubMed ID: 11521516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-phospholipid syndrome nephropathy].
    Nochy D; Daugas E; Hill G; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiphospholipid antibody profile: implications for the evaluation and management of patients.
    Tincani A; Andreoli L; Casu C; Cattaneo R; Meroni P
    Lupus; 2010 Apr; 19(4):432-5. PubMed ID: 20353983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies.
    Comarmond C; Cacoub P
    Autoimmun Rev; 2013 May; 12(7):752-7. PubMed ID: 23282546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of anti-phospholipid antibody formation and action.
    de Groot PG
    Thromb Res; 2011 Feb; 127 Suppl 3():S40-2. PubMed ID: 21262437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiphospholipid antibodies in critical illness.
    Dentali F; Crowther M
    Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New insights on disorders of haemostasis in the antiphospholipid syndrome].
    Zawilska K
    Pol Arch Med Wewn; 2006 May; 115(5):491-9. PubMed ID: 17195368
    [No Abstract]   [Full Text] [Related]  

  • 50. [Beta2 glycoprotein-I--the main antigen in antiphospholipid syndrome].
    Musiał J
    Pol Arch Med Wewn; 2007; 117 Suppl():59-60. PubMed ID: 18778023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiphospholipid antibodies--we are not quite there yet.
    Urbanus RT; de Groot PG
    Blood Rev; 2011 Mar; 25(2):97-106. PubMed ID: 21242018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Kidney disease in antiphospholipid antibody syndrome].
    Scheen M; Cordes L; Haidar F; De Seigneux S
    Rev Med Suisse; 2024 Feb; 20(863):430-435. PubMed ID: 38415729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arterial stenosis in antiphospholipid syndrome: Update on the unrevealed mechanisms of an endothelial disease.
    Harifi G; Nour-Eldine W; Noureldine MHA; Berjaoui MB; Kallas R; Khoury R; Uthman I; Al-Saleh J; Khamashta MA
    Autoimmun Rev; 2018 Mar; 17(3):256-266. PubMed ID: 29339317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catastrophic antiphospholipid syndrome: first signs in the neonatal period.
    Cabral M; Abadesso C; Conde M; Almeida H; Carreiro H
    Eur J Pediatr; 2011 Dec; 170(12):1577-83. PubMed ID: 21845393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
    de Laat B; Mertens K; de Groot PG
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
    Pierangeli SS; Erkan D
    Lupus; 2010 Apr; 19(4):475-85. PubMed ID: 20353991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiphospholipid syndrome in renal transplantation.
    Barbour TD; Crosthwaite A; Chow K; Finlay MJ; Better N; Hughes PD; Cohney SJ
    Nephrology (Carlton); 2014 Apr; 19(4):177-85. PubMed ID: 24548061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiphospholipid syndrome.
    George D; Erkan D
    Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.